Holen Sie sich die Stockscreener-App
9.67
0.83%
0.08
Schlusskurs vom Vortag:
$9.59
Offen:
$9.7
24-Stunden-Volumen:
302.94K
Relative Volume:
0.35
Marktkapitalisierung:
$1.20B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
967.00
EPS:
0.01
Netto-Cashflow:
$-383.00M
1W Leistung:
-0.31%
1M Leistung:
-1.63%
6M Leistung:
-2.32%
1J Leistung:
-53.40%
1-Tages-Spanne:
$9.59
$9.92
1-Wochen-Bereich:
$9.02
$10.10
52-Wochen-Spanne:
$7.33
$22.53
Indivior Plc Stock (INDV) Company Profile
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
9.67 | 1.20B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
159.63 | 71.40B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.36B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.14 | 46.03B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.41 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.26 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Indivior Plc Aktie (INDV) Neueste Nachrichten
Madison Avenue Partners Increases Stake in Indivior PLC - TipRanks
Global Naloxone Market to Witness Remarkable Growth with Indivior PLC, Akorn, Inc., Hikma Pharmaceuticals PLC, - EIN News
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Off - GuruFocus.com
Indivior CEO’s Share Interests Updated Following LTIP Award Release - TipRanks
Indivior Director Increases Shareholding, Signaling Confidence - TipRanks
(INDV) Technical Data - Stock Traders Daily
Indivior PLC Grants Long-Term Incentive Awards to Key Executives - TipRanks
Investors who lost money on Indivior PLC(INDV) should contact Levi & Korsinsky about pending Class ActionINDV - ACCESS Newswire
Indivior Executive and Associate Increase Shareholding - TipRanks
Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus.com
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire
Indivior Announces Further Changes to Board of Directors - GuruFocus.com
Indivior streamlines board ahead of AGM - Investing.com India
Indivior streamlines board ahead of AGM By Investing.com - Investing.com South Africa
Indivior PLC Announces Change in Major Holdings - TipRanks
Shareholder Rights Advocates at Levi & Korsinsky Investigate Indivior PLC (INDV) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Indivior PLC Announces Vesting of Long-Term Incentive Plan Awards - TipRanks
Indivior shrinks board following pressure from activist investor - ShareCast
Indivior Announces Strategic Board Restructuring - TipRanks
REGIndivior PLCFurther Changes to Board of Directors - TradingView
Earnings To Watch: Indivior PLC (INDV) Reports Q4 2024 Result - GuruFocus.com
Indivior PLC Updates on Total Voting Rights and Capital - TipRanks
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders - ACCESS Newswire
Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Insider Spends US$399k Buying More Shares In Indivior - Simply Wall St
Shareholders that lost money on Indivior PLC(INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
VELA Investment Management LLC Has $2.26 Million Stock Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior (NASDAQ:INDV) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Richmond InnoChesterfield pharma company Indivior announces CEO change - The Business Journals
Stockpickers: Indivior highlights the difficulty of finding a cure - Financial Times
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
(INDV) Investment Analysis - Stock Traders Daily
Indivior Director Acquires 15,000 Shares, Signaling Confidence - TipRanks
Levi & Korsinsky Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior FY2025 EPS Estimate Lowered by Northland Capmk - MarketBeat
Indivior PLC Sees Change in Major Shareholding as Morgan Stanley Adjusts Position - TipRanks
Indivior CEO exits as activist shareholder Oaktree presses for change - BioCentury
Class Action Filed Against Indivior PLC (INDV) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Indivior Director Increases Stake with Share Purchase - TipRanks
Indivior Chair Acquires 10,000 Shares, Signaling Confidence in Company’s Future - TipRanks
Indivior names former Collegium Pharmaceutical chief as CEO -February 27, 2025 at 09:48 am EST - Marketscreener.com
Indivior CEO Mark Crossley to step down, Joe Ciaffoni to succeed - TipRanks
Indivior names Joseph Ciaffoni as new CEO By Investing.com - Investing.com Canada
Pharma veteran Ciaffoni to take CEO reins at Indivior - ShareCast
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - The Malaysian Reserve
Indivior names Joseph Ciaffoni as new CEO - Investing.com India
UK's Indivior appoints Joe Ciaffoni as CEO - Reuters.com
Indivior Appoints Joe Ciaffoni as New CEO to Drive Growth - TipRanks
Indo-Asian News Service-INDIVIOR ANNOUNCES JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER - IANS India Pvt Ltd
Indivior PLC Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.67%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):